Based on single-cell RNA-Seq, we found that a larger fraction of S-specific MBCs derived from patients with IBD treated with anti-TNF were aMBCs and MZ-like B cells, whereas cMBCs were the most frequent population in the healthy control group and patients treated with anti-IL-12/23. The gene discussed is TNF; the disease is inflammatory bowel disease.